drugset
drugset / Trial / NCT03146130

Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders

NCT03146130 ↗

Phase 3 Terminated 14 enrolled Centre Hospitalier Universitaire, Amiens
RandomizedParallel-groupDouble-blindTreatment

Summary

Impulse control disorders encountered in Parkinson's disease (PD) are induced by dopaminergic medications and their frequency is estimated to be nearly 20%, mainly under dopaminergic agonists (AD).

Timeline

Start
2019-01-23
Primary completion
2024-02-09
Completion
2026-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule — —

Indications

Parkinson disease impulse control disorder